Subcutaneous and sublingual levodopa methyl ester in Parkinson's disease

J Neurol Neurosurg Psychiatry. 1991 Apr;54(4):373. doi: 10.1136/jnnp.54.4.373.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Administration, Sublingual
  • Antiparkinson Agents*
  • Drug Administration Schedule
  • Female
  • Humans
  • Injections, Subcutaneous
  • Levodopa / administration & dosage
  • Levodopa / analogs & derivatives*
  • Male
  • Middle Aged
  • Neurologic Examination
  • Parkinson Disease / drug therapy*

Substances

  • Antiparkinson Agents
  • Levodopa
  • levodopa methyl ester